Aveo Oncology
  • Home
  • Contact Us
  • About AVEO
    • The Human Response
    • Management Team
    • Board of Directors
    • Scientific Advisors
    • Our Partners
      • Areas of Interest
  • Our Product Candidates
    • Overview
    • Tivozanib
      • Renal Cell Carcinoma
      • Tivozanib Clinical Development
      • VEGF in Solid Tumors
    • Ficlatuzumab
    • AV-203
  • R & D
    • Overview
    • Human Response Platform™
    • Discovery Programs
  • For Patients & Caregivers
    • Overview
    • About Kidney Cancer
    • Clinical Trials
  • For Investors
  • For Media
    • Press Releases
    • Additional Resources
  • Join Our Team
    • Overview
    • Benefits
    • Career Opportunities
  • For Investors
  • Investor Home
  • Corporate Governance
  • Stock Information
  • Research Coverage
  • SEC Filings
  • Press Releases
  • Scientific Publications & Presentations
  • Calendar of Events
  • FAQs
  • Information Request
Print PagePrint Page
E-mail PageE-mail Page
RSS FeedsRSS Feeds
E-mail AlertsE-mail Alerts
IR ContactsIR Contacts
Financial Tear SheetFinancial Tear Sheet

Event Details

The human Response

© AVEO Pharmaceuticals, Inc. All rights reserved.

  • Twitter
  • Youtube

Contact Us  |  Site Map  |  Terms of Use  |  Privacy Policy